Krystal Biotech Statistics Share Statistics Krystal Biotech has 28.94M
shares outstanding. The number of shares has increased by 0.59%
in one year.
Shares Outstanding 28.94M Shares Change (YoY) 0.59% Shares Change (QoQ) 0.32% Owned by Institutions (%) 94.82% Shares Floating 24.86M Failed to Deliver (FTD) Shares 468 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 3.14M, so 10.87% of the outstanding
shares have been sold short.
Short Interest 3.14M Short % of Shares Out 10.87% Short % of Float 18.24% Short Ratio (days to cover) 11.16
Valuation Ratios The PE ratio is 50.24 and the forward
PE ratio is 17.59.
Krystal Biotech's PEG ratio is
0.07.
PE Ratio 50.24 Forward PE 17.59 PS Ratio 15.42 Forward PS 7 PB Ratio 4.73 P/FCF Ratio 37.58 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Krystal Biotech has an Enterprise Value (EV) of 4.14B.
EV / Sales 14.26 EV / EBITDA 37.68 EV / EBIT 33.56 EV / FCF 34.75
Financial Position The company has a current ratio of 7.28,
with a Debt / Equity ratio of 0.01.
Current Ratio 7.28 Quick Ratio 7.02 Debt / Equity 0.01 Debt / EBITDA 0.07 Debt / FCF 0.06 Interest Coverage 0
Financial Efficiency Return on Equity is 9.42% and Return on Invested Capital is 6.43%.
Return on Equity 9.42% Return on Assets 8.44% Return on Invested Capital 6.43% Revenue Per Employee $1.06M Profits Per Employee $324.21K Employee Count 275 Asset Turnover 0.28 Inventory Turnover 0.76
Taxes Income Tax 6.2M Effective Tax Rate 6.5%
Stock Price Statistics The stock price has increased by -25.39% in the
last 52 weeks. The beta is 0.7, so Krystal Biotech's
price volatility has been higher than the market average.
Beta 0.7 52-Week Price Change -25.39% 50-Day Moving Average 141.47 200-Day Moving Average 160.89 Relative Strength Index (RSI) 42.8 Average Volume (20 Days) 384,896
Income Statement In the last 12 months, Krystal Biotech had revenue of 290.51M
and earned 89.16M
in profits. Earnings per share was 3.12.
Revenue 290.51M Gross Profit 270.45M Operating Income 65.69M Net Income 89.16M EBITDA 109.91M EBIT 103.19M Earnings Per Share (EPS) 3.12
Full Income Statement Balance Sheet The company has 344.87M in cash and 7.26M in
debt, giving a net cash position of 337.6M.
Cash & Cash Equivalents 344.87M Total Debt 7.26M Net Cash 337.6M Retained Earnings -180.67M Total Assets 1.14B Working Capital 754.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 123.42M
and capital expenditures -4.24M, giving a free cash flow of 119.18M.
Operating Cash Flow 123.42M Capital Expenditures -4.24M Free Cash Flow 119.18M FCF Per Share 4.17
Full Cash Flow Statement Margins Gross margin is 93.09%, with operating and profit margins of 22.61% and 30.69%.
Gross Margin 93.09% Operating Margin 22.61% Pretax Margin 32.82% Profit Margin 30.69% EBITDA Margin 37.83% EBIT Margin 22.61% FCF Margin 41.02%
